MASSDEVICE ON CALL — Waltham, Mass.-based NeuroMetrix (NSDQ:NURO) announced its support of the Joslin Diabetes Center’s "Why Wait" program targeting obese patients with diabetes.
The clinical study will attempt to discover whether outpatient weight and lifestyle management programs can affect diabetic peripheral neuropathy, a condition which affects more than half of people with diabetes and is the primary trigger diabetic foot ulcers which may require lower extremity amputations, according to a press release.
Researchers will follow 50 patients on an outpatient basis for 1 year, during which time doctors will monitor nerve conduction using NeuroMetrix’s NC-stat DPNCheck quantitative test for the evaluation of systemic neuropathies.
"We are pleased to have the opportunity to support this study at Joslin, which is world renowned for its clinical and basic science work in diabetes," NeuroMetrix president & CEO Dr. Shai Gozani said in prepared remarks. "There has been speculation concerning the extent to which weight loss and intensive lifestyle management can impact diabetic microvascular complications such as peripheral neuropathy. This study is designed to make an important contribution to the debate, and will also demonstrate the diagnostic and monitoring efficacy of our NC-stat DPNCheck device."
NURO shares were up 2% to about 75¢ as of about 12:30 p.m. today.
Smith & Nephew to lay off up to 100
U.K.-based orthopedic giant Smith & Nephew (NYSE:SNN) laid off 40 and may cut up to 60 more as it closes a British manufacturing facility and moves some of its operation to China, Bloomberg reported.
Bipartisan effort to mull over FDA user fees this week
Congressional Democrats and Republicans this week will work together to come to terms on the reauthorization of FDA user fees on medical device and drug makers ahead of a Sept. 30 deadline, Healthwatch reported.
Boston Scientific completes enrollment in Reprise I trial of Lotus aortic valve system
Boston Scientific (NYSE:BSX) completed enrollment in its Australian Reprise I single-arm feasibility study evaluating its Lotus aortic valve system, which it bills as the 1st transcatheter aortic valve replacement technology of its kind, according to a press release.
New Medicare report warns on aging population and slow economy
A new report released today on Medicare noted that the program " is in worse shape than Social Security because of rising health care costs," especially in the face of an aging population and a slowly recovering economy, the Washington Post reported.
